The overall goal of the Outreach Core of the MSM/TU/UAB CCC Partnership is to implement and evaluate, Cancer Care Connect, an innovative enhanced care coordination model for cancer survivors that links health system patient navigators (HSPNs) and survivorship care plans (SCPs) with community-based patient navigators (CBPNs) to improve satisfaction with care, satisfaction with navigation services, and quality of life among cancer survivors. The accomplishment of the study's goal will be facilitated by the Partnership's decade-long history of recruiting, training, and engaging lay community health workers/advisors to promote age-appropriate cancer screening, healthy lifestyles, and enrollment in cancer clinical trials. The patient navigation model used by the Partnership has been successful in the context of cancer prevention, and now it will be expanded to cover the entire cancer continuum, from diagnosis through survivorship. To our knowledge, this will be the first study to extend patient care coordination from the health system to the community using community navigation and SCPs. Following a baseline assessment, patients with a HSPN and SCP will be linked to a CBPN, and the impact of the combined health system-based and community-based navigation will be evaluated at multiple time points. We anticipate that cancer survivors receiving the Cancer Care Connect will increase satisfaction with care, increase satisfaction with navigation services, and improved quality of life.

Public Health Relevance

The goal of the Outreach Core is to implement and evaluate an innovative plan for care of cancer survivors. In the proposed effort, ?patient navigators?, who are trained to assist patients to gain benefit of the healthcare system and are provided by the health system, will be linked with lay, community-based navigators and survivorship care plans (SCPs) to improve satisfaction with care and quality of life among cancer survivors. This will be the first study to extend coordination of patient care from the health system to the community by use of navigators and SCP.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA118948-12
Application #
9357533
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2005-09-30
Project End
Budget Start
2017-09-01
Budget End
2018-08-31
Support Year
12
Fiscal Year
2017
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Luo, Yanzhuo; Li, Bingjin; Zhang, Guangxin et al. (2018) Integrated Oncogenomic Profiling of Copy Numbers and Gene Expression in Lung Adenocarcinomas without EGFR Mutations or ALK Fusion. J Cancer 9:1096-1105
Wang, Chiung-Min; Yang, William H; Liu, Runhua et al. (2018) FOXP3 Activates SUMO-Conjugating UBC9 Gene in MCF7 Breast Cancer Cells. Int J Mol Sci 19:
Moore, Justin Xavier; Royston, Kendra J; Langston, Marvin E et al. (2018) Mapping hot spots of breast cancer mortality in the United States: place matters for Blacks and Hispanics. Cancer Causes Control :
Akinyemiju, Tomi; Moore, Justin Xavier; Pisu, Maria et al. (2018) A Prospective Study of Obesity, Metabolic Health, and Cancer Mortality. Obesity (Silver Spring) 26:193-201
Akinyemiju, Tomi; Moore, Justin Xavier; Judd, Suzanne E et al. (2018) Pre-diagnostic biomarkers of metabolic dysregulation and cancer mortality. Oncotarget 9:16099-16109
Piyathilake, Chandrika J; Badiga, Suguna; Borak, Samuel G et al. (2017) A higher degree of expression of DNA methyl transferase 1 in cervical cancer is associated with poor survival outcome. Int J Womens Health 9:413-420
Williams, Samuel K; Braxton, Joanne M; Gosdin, Melissa et al. (2017) Evidence-Based Care for the Elderly: Uses of ""the Grandmother Principle"". J Health Care Poor Underserved 28:7
Gao, Song; Wang, Yicun; Wang, Meng et al. (2017) MicroRNA-155, induced by FOXP3 through transcriptional repression of BRCA1, is associated with tumor initiation in human breast cancer. Oncotarget 8:41451-41464
Jia, Xu; Shanmugam, Chandrakumar; Paluri, Ravi K et al. (2017) Prognostic value of loss of heterozygosity and sub-cellular localization of SMAD4 varies with tumor stage in colorectal cancer. Oncotarget 8:20198-20212
Zhang, Yifan; Li, Bingjin; Zhang, Xingyi et al. (2017) CD24 is a genetic modifier for risk and progression of prostate cancer. Mol Carcinog 56:641-650

Showing the most recent 10 out of 193 publications